New cll drugs

For people struggling with relapsed or refractory CLL or SLL, current treatment choices are limited, said Brian Koffman, MD, cofounder and chief medical officer of the CLL Society and a CLL survivor himself. The approval of Breyanzi as the first CAR T-cell therapy available for relapsed or refractory CLL or SLL brings new hope to these

leukaemia (CLL) Researchers around the world are looking into the causes, diagnosis and treatment of CLL. They are also looking into whether new treatments are

A new drug treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL) is showing promise during clinical trials.

Four new drugs transform CLL treatment. Four new drugs transform CLL FDA approves two immunotherapies for melanoma. FDA approves two immunotherapies

We provide input regarding living with CLL/SLL as patients and care partners, experience with current treatments and expectations for a new drug.

New Patient Appointments Radiation Therapy for CLL Stem Cell Transplant for CLL Investigational Approaches Immunotherapy New Therapeutic Drugs Ongoing

Emerging treatments could change the future for people with CLL. Immunotherapies and other new drugs are already extending survival. In the near future, new combinations of drugs and other types

New Drug Combination for CLL Treatment. The UNITY study has introduced the promising new drug combination of umbralisib plus ublituximab as a

A Phase 3 trial of a new drug, zanubrutinib, represents a new and more successful treatment for people with Chronic Lymphocytic Leukemia (CLL).